Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Advice for secondary clinicians regarding caring for trial participants

If you are caring for a patient enrolled in the PRINCIPLE trial who is taking a study medication, please be aware that 

  • They should only continue the study medication if you judge it is clinically safe to do so: treatment decisions, including study medications, remain the responsibility of the clinical team.
  • We will continue to follow up PRINCIPLE trial participants until 28 days after trial entry.
  • We are working in partnership with RECOVERY and RECOVERY-RS Trials.
    Details regarding the possibility of recruitment into these trials can be found here.